Jubilant Pharmova Limited (BSE: 530019)
Health Care · Pharmaceuticals · IN
Rs931.20
-6.94% today · -16.8% 1Y
Jubilant Pharmova Limited (BSE: 530019) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.52B.
Over the last twelve months the share price has lost 16.8%, trading between 783.75 and 1.18K.
Tweenvest scores Jubilant Pharmova Limited across four factors: quality 65/100, value 45/100, growth 45/100, dividend 27/100. Its strongest factor is quality.
530019 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.52B
- Revenue (TTM)
- $910.43M
- P/E
- 42.00
- EPS
- 22.17
- Dividend yield
- 0.54%
- Beta (5Y)
- 0.47
- 52-week high
- Rs1,183.90
- 52-week low
- Rs783.75
- Avg volume (3M)
- —
- Shares outstanding
- 158.39M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Square Pharmaceuticals PLC.DSE: SQURPHARMA | $1.56B | Tk217.10 | -0.55% |
| Phibro Animal Health CorporationNasdaqGM: PAHC | $1.56B | $37.75 | -1.44% |
| North China Pharmaceutical Company.LtdSHSE: 600812 | $1.54B | CN¥6.03 | +21.08% |
| Innoviva, Inc.NasdaqGS: INVA | $1.53B | $21.46 | +1.18% |
| Lotus Pharmaceutical Co., Ltd.TWSE: 1795 | $1.52B | NT$180.50 | +2.56% |
| Caregen Co., Ltd.KOSDAQ: A214370 | $1.52B | ₩41,800.00 | -1.76% |
| AstraZeneca Pharma India LimitedBSE: 506820 | $1.51B | Rs5,831.85 | -3.29% |
| Maze Therapeutics, Inc.NasdaqGM: MAZE | $1.51B | $28.51 | +5.15% |
Figures last refreshed Oct 11, 2026.